Browsing eNauka
Browsing by Project Roche
Showing results 1 to 20 of 81
next >
Issue Date | Title | Author(s) | Type | М-cat. |
---|---|---|---|---|
2017 | A Cross-Sectional Study On Predictors Of Lung Cancer Patients Delay Time In Serbia (✓) | Jovanovic, Dragana D; Perin, Branislav M; Velinovic, Milos M; Rancic, Milan H ![]() ![]() | Conference Paper | Mp. category will be shown later |
2023 | A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care (✓) | El-Galaly, Tarec Christoffer; ...; Antić, Darko A. ![]() ![]() | Article | 21M21 |
2016 | Addressing challenges for sustainable healthcare in Central and Eastern Europe | Godman, Brian; Novakovic, Tanja; Tesic, Danka; Oortwijn, Wija; Martin, Antony Paul; Parker, Mark; Haycox, Alan | Article | 22M22 |
2018 | Alemtuzumab and pregnancy - case series from the German MS and Pregnancy Registry, Norway and Serbia | Celius, EG; Ciplea, AI; Drulovic, Jelena S ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2018 | Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome (✓) | Schwartz, GG; ...; Dilić, Mirza; ...; Ristić, Arsen D. ![]() ![]() ![]() ![]() ![]() ![]()
Ašanin, Milika R.
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21aM21a |
2019 | Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaign | Suppa, M; ...; Medenica, Ljiljana M; ...; (broj, koautora 38) | Article | 21aM21a |
2021 | Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB plus ) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C | Dziadziuszko, R; ...; Andric, Zoran G; ...; (broj, koautora 20) | Conference Paper | Mp. category will be shown later |
2020 | Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC | Herbst, Roy S; ...; Andric, Zoran G; ...; (broj, koautora 22) | Article | 21aM21a |
2022 | Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial | Peters, Solange; ...; Andric, Zoran G; ...; (broj, koautora 26) | Article | 21aM21a |
2019 | Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry | Cifkova, Renata; Lanska, Vera; Bruthans, Jan; Mayer, Otto Jr; Kotseva, Kornelia; Wood, David; Lovic, Dragan B ![]() ![]()
Deckers, Jaap; Gotcheva, Nina; Georgiev, Borislav; De, Bacquer Dirk;
| Article | 21M21 |
2017 | Brain and spinal cord imaging features in neuromyelitis optica spectrum disorder | Cacciaguerra, Laura; Rocca, Maria Assunta; Mesaros, Sarlota T; Radaelli, Marta; Drulovic, Jelena S ![]() ![]() | Conference Paper | Mp. category will be shown later |
2023 | Cerebrospinal fluid and MRI analyses of fenebrutinib treatment in multiple sclerosis reveal brain penetration and early reduction of new lesion activity: results from the phase II FENopta study | Bar-Or, Amit; Dufek, Michal; Budincevic, Hrvoje; Drulovic, Jelena S ![]() ![]()
Kuruvilla, Denison; Qi, Qi; Xu, Yan; Goodyear, Alexandra; Oh, Jiwon;
| Conference Paper | Mp. category will be shown later |
2016 | Cerebrospinal fluid chitinase 3-like 1 levels in patients with radiologically isolated syndromes | Matute-Blanch, Clara; ...; Drulovic, Jelena S ![]() ![]() | Conference Paper | Mp. category will be shown later |
2015 | Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents | Karmiris, Konstantinos; ...; Tarabar, Dino K; ...; (broj, koautora 20) | Article | 21M21 |
2020 | Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110 | Herbst, Roy S; ...; Andric, Zoran G; ...; (broj, koautora 21) | Conference Paper | Mp. category will be shown later |
2019 | Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by SP142, SP263 and 22C3 PD-L1 immunohistochemistry (IHC) assays and by blood tumour mutational burden (bTMB): Results from the IMpower110 study | Herbst, Roy S; ...; Andric, Zoran G; ...; (broj, koautora 20) | Conference Paper | Mp. category will be shown later |
2012 | Clinical Efficacy of Etanercept Versus Sulfasalazine in Ankylosing Spondylitis Subjects with Peripheral Joint Involvement | Braun, Juergen; Pavelka, Karel; Ramos-Remus, Cesar; Dimic, Aleksandar N; Vlahos, Bonnie; Freundlich, Bruce; Koenig, Andrew S | Article | 22M22 |
2022 | Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia | Verlohren, Stefan; Brennecke, Shaun P; Galindo, Alberto; Karumanchi, Ananth S; Mirkovic, Ljiljana B; Schlembach, Dietmar; Stepan, Holger; Vatish, Manu; Zeisler, Harald; Rana, Sarosh | Article | 22M22 |
2022 | Clinical Trial Readiness for Spinal Muscular Atrophy: Experience of an International Educational-Training Initiative | Tizzano, Eduardo F; Christie-Brown, Vanessa; Baranello, Giovanni; Germanenko, Olga; Gray, Allyson; Krstic, Marija; Lilien, Charlotte; Patel, Hinal; Servais, Laurent; Scoto, Mariacristina | Article | 22M22 |
2018 | Collagen Degradation and Formation Are Elevated in Exacerbated COPD Compared With Stable Disease | Schumann, Desiree M; ...; Milenkovic, Branislava A; ...; (broj, koautora 18) | Article | 21aM21a |